Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Amazon to buy PillPack in potentially disruptive drug retail push
-
Cantor Fitzgerald Reiterates Overweight on Neos Therapeutics (NEOS) Following Management Changes
-
CohBar Completes Sale of $20 Million Under Controlled Equity Offering
-
CohBar Completes Sale of $20 Million Under Controlled Equity Offering
-
Cantor Fitzgerald Downgrades Aquinox Pharmaceutical (AQXP) to Neutral
-
UPDATE: Global Blood Therapeutics (GBT) PT Raised to Street High $96 at Cantor Fitzgerald
-
Makor Enters Strategic Partnership With Investre
-
Layton Road Group Welcomes Managing Director Daniel Cohen
-
Cantor Fitzgerald Reiterates Overweight on Apellis Pharmaceuticals (APLS) Following R&D Day
-
PolarityTE (COOL) Bullish View Reiterated at Cantor Fitzgerald Following Call
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
electroCore, Inc. Announces Closing of Initial Public Offering
-
SELLAS Life Sciences (SLS) Plans 6.08M Share Public Offering of Common Stock
-
SELLAS Life Sciences Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald to Host Conf Call with PolarityTE (COOL) Management Tomorrow
-
Long-dated notes gain on trade war, Europe concerns
-
GW Pharma (GWPH) PT Raised to Street High $235 at Cantor Fitzgerald
-
Kindred Biosciences (KIN) Reports Exercise of Option by Underwriters to Purchase Additional 694.74K Shares at $9.50/Sh
-
Kindred Biosciences Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
-
Array BioPharma (ARRY) PT Raised to $26 at Cantor Fitzgerald
-
electroCore (ECOR) IPO Opens 20% Higher
-
electroCore, Inc. (ECOR) Prices 5.2M Share IPO at $15/Sh
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
electroCore, Inc. Announces Pricing of Initial Public Offering
-
Thunder Bridge Acquisition, Ltd. Announces Closing of $225,000,000 Initial Public Offering
-
Two More Positive HTX-011 Studies Supports Bullish Heron Therapeutics (HRTX) Thesis - Cantor Fitzgerald
-
UPDATE: Quality Systems (QSII) PT Raised to $23 at Cantor Fitzgerald
-
Kindred Biosciences (KIN) Prices 4.63M Share Common Offering at $9.50/Sh
-
Kindred Biosciences Announces Pricing of Public Offering
-
Galmed Pharma (GLMD) Prices 5M Share Common Offering at $15/Sh
-
Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares
-
Orchid Island Capital Announces June 2018 Monthly Dividend and May 31, 2018 RMBS Portfolio Characteristics
-
Kindred Biosciences (KIN) to Offer Common Stock
-
Kindred Biosciences Announces Proposed Public Offering of Common Stock
-
Cantor Still Likes Valeant Pharma (VRX) Despite The CRL
-
Thunder Bridge Acquisition, Ltd. Announces Pricing of $225,000,000 Initial Public Offering
-
Valeant Pharmaceuticals (VRX) PT Raised to $32 at Cantor Fitzgerald
-
Galmed Pharma (GLMD) Proposed $75M Public Offering of Ordinary Shares
-
Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares
-
Centene (CNC) PT Raised to $137 at Cantor Fitzgerald
-
bluebird bio (BLUE) is Fundamentally Overvalued - Cantor
-
Verastem (VSTM) Capital Raise Removes Overhang - Cantor Fitzgerald
-
Prothena Corp (PRTA) PT Raised to $18 at Cantor Fitzgerald; 'To Reflect Restructuring'
-
U.S.-China trade fight leads stocks lower, oil sinks on supply fears
-
Max Sound Files Regulatory Complaints To Expose Manipulative Trading Practices and Abusive Naked Short Selling by Major Market Makers
-
ProPhotonix Secures �700,000 Term Loan - STKR
-
Explains Illegal Naked Shorting Being Perpetrated By Major Market Makers on MAXD Shares
-
Global Blood Therapeutics (GBT): Look For Efficacy Data From EHA Over The Next Two Days - Cantor
-
Max Sound Corporation Announces Short Squeeze Situation On Its Stock
-
STRATA Skin Sciences to Participate in Panel Discussion at Cantor Fitzgerald Dermatology & Aesthetics Summit

